X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1417) 1417
humans (1312) 1312
valine - analogs & derivatives (1151) 1151
male (906) 906
female (827) 827
valine - therapeutic use (708) 708
valsartan (650) 650
middle aged (617) 617
adult (481) 481
valine - adverse effects (451) 451
aged (447) 447
tetrazoles - therapeutic use (417) 417
valine - administration & dosage (360) 360
acyclovir - analogs & derivatives (355) 355
hypertension - drug therapy (342) 342
treatment outcome (307) 307
animals (275) 275
tetrazoles - adverse effects (261) 261
antihypertensive agents - therapeutic use (255) 255
pharmacology & pharmacy (253) 253
acyclovir - therapeutic use (249) 249
antiviral agents - therapeutic use (237) 237
hypertension (230) 230
double-blind method (226) 226
valine - pharmacology (220) 220
drug therapy, combination (214) 214
blood pressure - drug effects (211) 211
tetrazoles - administration & dosage (210) 210
valine (205) 205
antihypertensive agents - adverse effects (185) 185
abridged index medicus (174) 174
angiotensin ii type 1 receptor blockers - therapeutic use (172) 172
acyclovir - adverse effects (151) 151
valacyclovir (147) 147
antihypertensive agents - administration & dosage (145) 145
drug therapy (143) 143
antiviral agents - adverse effects (142) 142
dose-response relationship, drug (141) 141
risk factors (139) 139
rats (138) 138
tetrazoles - pharmacology (137) 137
time factors (133) 133
peripheral vascular disease (131) 131
adolescent (129) 129
medicine, general & internal (124) 124
cardiac & cardiovascular systems (119) 119
acyclovir - administration & dosage (117) 117
hypertension - physiopathology (117) 117
valine - genetics (116) 116
analysis (115) 115
double-blind (115) 115
aged, 80 and over (114) 114
angiotensin-converting enzyme inhibitors - therapeutic use (106) 106
antiviral agents - administration & dosage (106) 106
acyclovir (105) 105
amino acids (105) 105
prospective studies (103) 103
mortality (101) 101
prevention (101) 101
research (101) 101
therapy (97) 97
administration, oral (96) 96
health aspects (94) 94
angiotensin ii type 1 receptor blockers - adverse effects (93) 93
blood-pressure (93) 93
follow-up studies (93) 93
leucine (93) 93
neurosciences (92) 92
blood pressure (91) 91
heart failure - drug therapy (90) 90
valine - pharmacokinetics (90) 90
angiotensin receptor antagonists (89) 89
disease (89) 89
metabolism (88) 88
care and treatment (86) 86
young adult (86) 86
randomized controlled trials as topic (84) 84
genotype (83) 83
isoleucine (83) 83
risk (83) 83
internal medicine (82) 82
amlodipine (81) 81
trial (78) 78
angiotensin (77) 77
heart failure (77) 77
mice (76) 76
efficacy (74) 74
drug combinations (73) 73
management (73) 73
oncology (73) 73
antihypertensive agents - pharmacology (70) 70
methionine - genetics (69) 69
medicine & public health (68) 68
psychiatry (68) 68
amlodipine - therapeutic use (67) 67
hydrochlorothiazide - therapeutic use (67) 67
toxicology (66) 66
herpes zoster - drug therapy (65) 65
hydrochlorothiazide - administration & dosage (65) 65
losartan (65) 65
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1523) 1523
German (29) 29
Spanish (14) 14
French (12) 12
Russian (11) 11
Japanese (10) 10
Chinese (7) 7
Italian (3) 3
Swedish (3) 3
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biological trace element research, ISSN 0163-4984, 02/2019, pp. 1 - 7
Cadmium (Cd), as one of the most toxic heavy metals, has become a widespread environmental contaminant and threats the food quality and safety. The protective... 
Aluminum | Toxicity | Poultry | Metals | Food contamination | Proline | Cytotoxicity | Amino acids | Lithium | Iron | Leucine | Tissues | Cobalt | Arginine | Profiles | Lead | Silicon | Food quality | Selenium | Lesions | Damage | Cadmium | Muscles | Mass spectroscopy | Principal components analysis | Aluminium | Heavy metals | Side effects | Inductively coupled plasma | Contaminants | Valine | Chickens | Chromium | Trace elements | Food safety | Mercury | Mass spectrometry | Manganese | Mercury (metal)
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9583, pp. 221 - 229
Journal Article
The Lancet, ISSN 0140-6736, 06/2004, Volume 363, Issue 9426, pp. 2022 - 2031
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the same blood-pressure control, valsartan... 
CALCIUM-CHANNEL BLOCKER | LIPID-LOWERING TREATMENT | RECEPTOR BLOCKER | MEDICINE, GENERAL & INTERNAL | ISOLATED SYSTOLIC HYPERTENSION | CONVERTING-ENZYME-INHIBITOR | DOUBLE-BLIND | ANGIOTENSIN-II | ELECTROCARDIOGRAPHIC IDENTIFICATION | CORONARY-ARTERY-DISEASE | BLOOD-PRESSURE | Calcium Channel Blockers - adverse effects | Valsartan | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - therapeutic use | Angiotensin II Type 1 Receptor Blockers | Endpoint Determination | Diuretics | Female | Blood Pressure - drug effects | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Valine - therapeutic use | Aged | Tetrazoles - adverse effects | Valine - adverse effects | Hydrochlorothiazide - therapeutic use | Hypertension | Medical research | Side effects | Drug therapy | Drugs | Heart attacks | Heart surgery | Angioplasty | Risk | Cardiovascular disease | Blood | Randomization | Measurement techniques | Blood pressure | Heart diseases | Age | Heart failure | Edema | Stroke | Mortality | Medical treatment | Health risks | Angina pectoris | Patients | Coronary artery disease | Morbidity | Hypotheses | Coronary vessels | Diabetes | Cardiovascular diseases | Health risk assessment | Mercury | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 16, pp. 1477 - 1490
In this large clinical trial, the angiotensin-receptor blocker valsartan reduced the risk of diabetes in patients with impaired glucose tolerance. However, the... 
FASTING GLUCOSE | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | LIFE-STYLE INTERVENTIONS | DISEASE | PREVENTION | COMPONENTS | IMPAIRED GLUCOSE-TOLERANCE | MELLITUS | CONVERTING-ENZYME-INHIBITORS | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Phenylalanine - analogs & derivatives | Valsartan | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Body Weight - drug effects | Male | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Cyclohexanes - therapeutic use | Glucose Intolerance - drug therapy | Exercise | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Phenylalanine - therapeutic use | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Blood Glucose - analysis | Double-Blind Method | Risk Factors | Valine - analogs & derivatives | Diabetes Mellitus, Type 2 - prevention & control | Proportional Hazards Models | Blood Glucose - drug effects | Glucose Intolerance - diet therapy | Tetrazoles - therapeutic use | Valine - therapeutic use | Tetrazoles - adverse effects | Valine - adverse effects | Glucose Intolerance - therapy | Evaluation | Care and treatment | Glucose intolerance | Diabetes | Cardiovascular diseases | Drug therapy | Cardiovascular disease | Index Medicus | Abridged Index Medicus | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2008, Volume 7, Issue 11, pp. 993 - 1000
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9579, pp. 2079 - 2087
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2008, Volume 52, Issue 3, pp. 501 - 506
Journal Article